Log in to save to my catalogue

Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent...

Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4839059

Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers

About this item

Full title

Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers

Publisher

Tokyo: Springer Japan

Journal title

Breast cancer (Tokyo, Japan), 2016-05, Vol.23 (3), p.445-455

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
There is an unmet need for specific and sensitive imaging techniques to assess the efficacy of breast cancer therapy, particularly Her-2-expressing cancers. Ultrasonic microbubbles are being developed for use as diagnostic and therapeutic tools. However, nanobubbles circulate longer, are smaller, and diffuse into extravascular tissue...

Alternative Titles

Full title

Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4839059

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4839059

Other Identifiers

ISSN

1340-6868

E-ISSN

1880-4233

DOI

10.1007/s12282-014-0581-8

How to access this item